132
Participants
Start Date
October 19, 2021
Primary Completion Date
July 28, 2022
Study Completion Date
September 5, 2022
MP1032
Hard gelatin capsules for oral administration.
Placebo
Placebo capsules matched to MP1032 for oral administration.
Richmond University Medical Center, Staten Island
Snake River Research PLLC, Idaho Falls
MHAT Blagoevgrad AD, Blagoevgrad
MHAT Sv. Ivan Rilski Kozloduy, Kozloduy
MHAT Dr. Stamen Iliev AD, Montana
SHATPD Pernik EOOD, Pernik
MHAT Dr. Ivan Seliminski AD, Sliven
"UmhatemN.I.Pirogov", Sofia
SHATPPD Sata Zagora EOOD, Stara Zagora
Centre Hospitalier Victor Dupouy, Argenteuil
CHU de Grenoble Alpes, Grenoble
Centre Hospitalier Lyon Sud, Pierre-Bénite
DE KK Infektológiai Klinika, Debrecen
Flor Ferenc Hospital of Pest County, Kistarcsa
Ospedale GB Morgagni, Forlì
Ospedale SM Goretti, Latina
ASST-FBF-SACCO - Ospedale Luigi Sacco, Milan
IRCCS Ospedale San Raffaele, Milan
Policlinico di Napoli, Napoli
"Ospedale Santo Spirito! Pescara", Pescara
Policlinico Agostino Gemelli, Roma
"Spitalul Clinic de Boli Infectioase si Tropicale Dr. Victor Babes", Bucharest
Spitalul Municipal Caracal, Caracal
"Spitalul Clinic de Boli Infectioase Sfanta Parascheva", Iași
Clinica Anestezie si Terapie Intensiva, Timișoara
Hospital Clinic de Barcelona Hospital Clinic i Provincial, Barcelona
Hospital Ramon y Cajal, Edificio Central, Madrid
Hospital Clínico Universitario de Salamanca, Salamanca
Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander
Hospital Universitario de Valme, Seville
Hospital Álvaro Cunqueiro, Vigo
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
MetrioPharm AG
INDUSTRY